应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02367 巨子生物
交易中 11-09 10:33:13
20.460
-0.200
-0.97%
最高
20.880
最低
20.400
成交量
58.96万
今开
20.680
昨收
20.660
日振幅
2.32%
总市值
217.29亿
流通市值
217.29亿
总股本
10.62亿
成交额
1,217万
换手率
0.06%
流通股本
10.62亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
【券商聚焦】中信证券:美妆行业普遍面临收入和净利率两个维度的压力
金吾财讯 · 11-06
【券商聚焦】中信证券:美妆行业普遍面临收入和净利率两个维度的压力
【券商聚焦】国泰海通证券:美护板块估值及持仓均处底位,看好成长型标的修复弹性
金吾财讯 · 11-05
【券商聚焦】国泰海通证券:美护板块估值及持仓均处底位,看好成长型标的修复弹性
巨子生物更新2026年10月股份变动月报,股本维持稳定
公告速递 · 11-04
巨子生物更新2026年10月股份变动月报,股本维持稳定
【券商聚焦】中信建投:中国医药资产全球性价比凸显,内外协同空间广阔
金吾财讯 · 11-02
【券商聚焦】中信建投:中国医药资产全球性价比凸显,内外协同空间广阔
超200亿医美巨头股价跌回三年前
深圳商报·读创 · 10-23
超200亿医美巨头股价跌回三年前
【券商聚焦】中信证券:美妆行业好于此前市场悲观预期
金吾财讯 · 10-23
【券商聚焦】中信证券:美妆行业好于此前市场悲观预期
港股异动 | 巨子生物(02367)再跌4%逼近前低 花旗指三季度未足够令人鼓舞 市场关注双十一表现
智通财经 · 10-22
港股异动 | 巨子生物(02367)再跌4%逼近前低 花旗指三季度未足够令人鼓舞 市场关注双十一表现
港股异动 | 巨子生物(02367.HK)盘中跌4%创近四年新低 花旗称其第三季尚未足够令人鼓舞
智通财经 · 10-21
港股异动 | 巨子生物(02367.HK)盘中跌4%创近四年新低 花旗称其第三季尚未足够令人鼓舞
花旗:中国化妆品第三季线上销售放缓 本地品牌表现较好
智通财经 · 10-20
花旗:中国化妆品第三季线上销售放缓 本地品牌表现较好
巨子生物推出新品牌1'me以我 天猫旗舰店上线首款精华液
北京商报 · 10-14
巨子生物推出新品牌1'me以我 天猫旗舰店上线首款精华液
三个月内回吐前期全部涨幅,“双十一”能否打响巨子生物(02367)股价翻身仗?
智通财经 · 10-14
三个月内回吐前期全部涨幅,“双十一”能否打响巨子生物(02367)股价翻身仗?
港股异动 | 大消费股多数上扬 国庆假期全国服务消费旺盛 低估值下消费配置动能有望上升
智通财经 · 10-09
港股异动 | 大消费股多数上扬 国庆假期全国服务消费旺盛 低估值下消费配置动能有望上升
巨子生物9月股本维持稳定,未有新增发行或回购
公告速递 · 10-06
巨子生物9月股本维持稳定,未有新增发行或回购
新消费概念板块受压 蔚来-SW(09866)跌2.74%、鸣鸣很忙(01768)跌2.03%
金吾财讯 · 10-05
新消费概念板块受压 蔚来-SW(09866)跌2.74%、鸣鸣很忙(01768)跌2.03%
【券商聚焦】中信证券:关注假期场景消费品类格局变化
金吾财讯 · 09-29
【券商聚焦】中信证券:关注假期场景消费品类格局变化
巨子生物2026年中期营收29.2亿元,经调整净利润9.5亿元
公告速递 · 09-24
巨子生物2026年中期营收29.2亿元,经调整净利润9.5亿元
【券商聚焦】华创证券维持巨子生物(02367)推荐评级 指医美新品打开增长空间
金吾财讯 · 09-22
【券商聚焦】华创证券维持巨子生物(02367)推荐评级 指医美新品打开增长空间
【券商聚焦】华泰证券:韩妆增长逻辑拆解与国潮美妆出海展望
金吾财讯 · 09-18
【券商聚焦】华泰证券:韩妆增长逻辑拆解与国潮美妆出海展望
长坡厚雪 “巨子”焕新
经济参考报 · 09-15
长坡厚雪 “巨子”焕新
【券商聚焦】招银国际:重点港股消费股的仓位结构趋于稳定
金吾财讯 · 09-10
【券商聚焦】招银国际:重点港股消费股的仓位结构趋于稳定
加载更多
公司概况
公司名称:
巨子生物
所属市场:
SEHK
上市日期:
--
主营业务:
巨子生物控股有限公司是一家主要从事基于生物活性成分的美丽与健康产品的研发、制造及销售业务的投资控股公司。该公司的主要产品包括功效性护肤品、医用敷料等专业皮肤护理产品,以及保健食品及其他产品。该公司主要在国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02367","market":"HK","secType":"STK","nameCN":"巨子生物","latestPrice":20.46,"timestamp":1794191531837,"preClose":20.66,"halted":0,"volume":589600,"delay":0,"changeRate":-0.009680542110358145,"floatShares":1061999999,"shares":1061999999,"eps":1.809999,"marketStatus":"交易中","change":-0.2,"latestTime":"11-09 10:33:13","open":20.68,"high":20.88,"low":20.4,"amount":12171634,"amplitude":0.023233,"askPrice":20.5,"askSize":4400,"bidPrice":20.46,"bidSize":9400,"shortable":3,"etf":0,"ttmEps":1.81589,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1794196800000},"marketStatusCode":2,"adr":0,"listingDate":1667491200000,"exchange":"SEHK","adjPreClose":20.66,"dividendRate":0.067884,"openAndCloseTimeList":[[1794187800000,1794196800000],[1794200400000,1794211200000]],"volumeRatio":0.621164,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02367","defaultTab":"news","newsList":[{"id":"2681188245","title":"【券商聚焦】中信证券:美妆行业普遍面临收入和净利率两个维度的压力","url":"https://stock-news.laohu8.com/highlight/detail?id=2681188245","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681188245?lang=zh_cn&edition=full","pubTime":"2026-11-06 09:04","pubTimestamp":1793927073,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券研究指,美妆板块在需求疲弱、线上运营成本上升、竞争持续高压的环境下,当前普遍面临收入和净利率两个维度的压力。各上市美妆公司的品牌/产品/渠道/公司治理等方面的差异决定了各自所处阶段的不同,当前快速成长期公司稀缺,低谷修复期公司增多。展望未来,头部企业主品牌有望陆续恢复增长,并通过多品牌、多品类、多领域、集团化等举措建立第二成长曲线,奠定下一阶段增长基础。风险提示:居民购买力或不达预期;流量和营销费用激增侵蚀净利率;美妆存量整合,竞争失序侵蚀业绩;医美对美妆产生结构性冲击;各公司布局多品牌、多品类导致管理难度加大,进而冲击业绩;政策监管超预期;重大舆情等黑天鹅事件等。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250110/YzMzOTE1NTA2MzA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/YzMzOTE1NTA2MzA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1995362","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2580892862.HKD","LU1997245094.SGD","LU1328615791.USD","SG9999004311.SGD","BK0196","LU1655091616.SGD","ZBmain","02367","LU2289578879.USD","BK1516","LU1997244956.HKD","BK1593","LU2148510915.USD","BK0183","LU0405327494.USD","LU1720050803.USD","LU1794554557.SGD","TNmain","ZNmain","BK0188","06030","LU1146622755.USD","LU1580142542.USD","BK0276","LU0455707207.USD","LU1255011170.USD","LU1781817850.SGD","LU2495084118.USD","LU0405327148.USD","LU1820825898.SGD","BK1147","ZFmain","BK1564","LU2580892789.USD","BK0012","BK1207","ZTmain","600030","BK0028","BK1215","LU1997245177.USD","UBmain","BK1521","KCE","LU1064131003.USD","01830","LU2242644610.SGD","02145","LU2488822045.USD","LU0502904849.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681090186","title":"【券商聚焦】国泰海通证券:美护板块估值及持仓均处底位,看好成长型标的修复弹性","url":"https://stock-news.laohu8.com/highlight/detail?id=2681090186","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681090186?lang=zh_cn&edition=full","pubTime":"2026-11-05 09:06","pubTimestamp":1793840817,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国泰海通证券研究指,26Q3美护板块收入/归母/扣非同比+10%/-36%/-29%,细分板块中个护稳健,美妆高端好于大众,医美下游好于上游,当前板块估值及持仓均处底位,看好成长型标的修复弹性。该机构推荐:1)基本面强劲的高成长标的;2)估值较低的龙头标的;3)预期低位、后续边际有望改善的标的。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1995267","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999004311.SGD","01530","LU0502904849.HKD","161027","01830","BK1593","02196","BK1147","LU2242644610.SGD","601211","02373","BK0201","BK1564","BK1100","BK0188","BK1585","BK0276","BK0184","02138","02611","BK1587","06699","BK0012","BK1161","LU2488822045.USD","01696","BK1207","BK1215","BK1515","00460","BK1600","BK1583","BK1511","BK0028","HK0000165453.HKD","02145","LU0455707207.USD","BK0183","BK1191","02367","KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136775902","title":"巨子生物更新2026年10月股份变动月报,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1136775902","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136775902?lang=zh_cn&edition=full","pubTime":"2026-11-04 16:43","pubTimestamp":1793781820,"startTime":"0","endTime":"0","summary":"巨子生物控股有限公司于2026年11月4日公布截至2026年10月31日的股份变动月报。公告显示,公司于10月期间整体股本结构保持不变。购股权方面,截至10月末,受2023年购股权计划影响的所有已授股份期权从上月结存的10,930,400股变动至期末结存为0股,期间并未实际行权,未有新股发行或从库存股转让。该公告由执行董事兼联席公司秘书严钰博签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680786312","title":"【券商聚焦】中信建投:中国医药资产全球性价比凸显,内外协同空间广阔","url":"https://stock-news.laohu8.com/highlight/detail?id=2680786312","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680786312?lang=zh_cn&edition=full","pubTime":"2026-11-02 08:46","pubTimestamp":1793580413,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券发布研报称,2026年欧洲内科肿瘤学会 中,中国创新药在多瘤种领域全面发力,众多项目从早期探索迈入III期临床或BLA/NDA阶段。该机构指,中国医药具有“创新升级+供应链韧性”优势,2025年创新药海外授权首付款大幅超去年全年,器械也在积极探索出海路径。美国主导早期研发与高端定价,但跨国药企专利悬崖下需求旺盛,中国资产全球性价比凸显,内外协同空间广阔。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1994939","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03069","03933","BK1610","01789","SG9999014674.SGD","01530","601066","09688","LU1720050803.USD","LU2399975544.HKD","LU0540923850.HKD","02228","LU0307460666.USD","LU2488822045.USD","600056","BK1161","IE00B5MMRT66.SGD","09926","LU0561508036.HKD","LU1969619763.USD","LU0588546209.SGD","SG9999004311.SGD","BK1100","BK1207","LU0348783233.USD","01099","KURE","LU1251922891.USD","IE00BPRC5H50.USD","LU2476274720.SGD","BK1515","02367","LU0634319403.HKD","LU0228659784.USD","LU0348735423.USD","LU0348825331.USD","02268","06160","02196","06821","LU0348766576.USD","LU0348767384.USD","LU0417516902.SGD","BK1588","BK1141","KCE","BK0028","LU2476274308.USD","BK1617","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677920372","title":"超200亿医美巨头股价跌回三年前","url":"https://stock-news.laohu8.com/highlight/detail?id=2677920372","media":"深圳商报·读创","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677920372?lang=zh_cn&edition=full","pubTime":"2026-10-23 21:16","pubTimestamp":1792761388,"startTime":"0","endTime":"0","summary":"10月20日,巨子生物全新品牌“1'me以我”登陆李佳琦直播间,核心原料为稀有人参皂苷。依托这项积淀十年的原料技术,巨子生物试图通过全新品牌形象,将这项技术推向大众消费市场。不过资本市场反应平淡。10月21日,医美巨头巨子生物盘中股价触及22.08港元,回吐近三年内全部涨幅。截至23日16:10,巨子生物报20.760港元/股,总市值回落至220.41亿港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610233906599219.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610233906599219.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2488822045.USD","02367","BK1207","SG9999004311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677913506","title":"【券商聚焦】中信证券:美妆行业好于此前市场悲观预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2677913506","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677913506?lang=zh_cn&edition=full","pubTime":"2026-10-23 08:40","pubTimestamp":1792716022,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券表示,2026年618大促中,国际品牌加码流量投放、叠加平台扶优致国货份额下降,竞争加剧使得行业投流成本上行,对核心上市公司收入及利润端造成影响,下半年以来美妆板块持续调整,隐含了市场对下半年及未来的悲观预期。双11已经启幕,价格体系整体稳健的前提下,销售情况总体好于市场此前悲观预期,未见格局的进一步恶化。国货品牌经历国际品牌的冲击和平台费用上行双重压力下,逐步显现出更强的品牌价值及经营韧性,美妆板块经历市值与预期的深度调整,投资价值已现。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1994275","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2495084118.USD","BK1564","LU0502904849.HKD","BK0188","LU2488822045.USD","LU1064130708.USD","BK0276","SG9999004311.SGD","BK1516","LU2580892862.HKD","LU1328615791.USD","600030","LU2242644610.SGD","02657","LU2289578879.USD","LU1655091616.SGD","LU1794554557.SGD","BK0183","BK0012","02367","LU0405327494.USD","LU2148510915.USD","LU1255011170.USD","LU0348766576.USD","LU2580892789.USD","LU0405327148.USD","BK1521","LU1146622755.USD","LU1997245177.USD","02145","LU0348767384.USD","LU1064131003.USD","LU1720050803.USD","06030","LU1820825898.SGD","01318","BK0028","KCE","LU1997244956.HKD","BK0196","LU1997245094.SGD","BK1207","LU1580142542.USD","LU1781817850.SGD","BK1147","LU0455707207.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677710981","title":"港股异动 | 巨子生物(02367)再跌4%逼近前低 花旗指三季度未足够令人鼓舞 市场关注双十一表现","url":"https://stock-news.laohu8.com/highlight/detail?id=2677710981","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677710981?lang=zh_cn&edition=full","pubTime":"2026-10-22 09:38","pubTimestamp":1792633095,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,巨子生物早盘跌超4%,盘中低见21.08港元,逼近历史前低20.485港元。截至发稿,跌4.12%,报21.42港元,成交额1558.17万港元。该行覆盖范围内,巨子生物品牌线上GMV正自低基数恢复,但第三季尚未足够令人鼓舞。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1510528.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1267930227.SGD","LU1506573853.SGD","LU0130517989.USD","LU1162221912.USD","LU0052756011.USD","LU2488822045.USD","IYF","LU0072461881.USD","LU0648001328.SGD","LU0477156953.USD","LU1074936037.SGD","LU1366192091.USD","LU0314106906.USD","LU0128525689.USD","LU0203345920.USD","LU0203347892.USD","VXUS","BK4585","LU1244550221.USD","BK1207","LU0106831901.USD","LU1244550494.USD","BK4207","LU0162691827.USD","LU2456880835.USD","BK4559","TFNS","LU0170899867.USD","LU1144417596.USD","LU1201861249.SGD","LU0098860793.USD","LU0130102774.USD","IE00BSNM7G36.USD","LU2462157665.USD","KCAI","BK4566","FTXO","LU2417539215.USD","BK4534","LU0310800965.SGD","BK4504","02367","LU1668664300.SGD","LU0320765646.SGD","LU1791807156.HKD","LU2125154778.USD","LU1244550577.SGD","BK4588","LU2236285917.USD","SG9999004311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677626887","title":"港股异动 | 巨子生物(02367.HK)盘中跌4%创近四年新低 花旗称其第三季尚未足够令人鼓舞","url":"https://stock-news.laohu8.com/highlight/detail?id=2677626887","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677626887?lang=zh_cn&edition=full","pubTime":"2026-10-21 15:47","pubTimestamp":1792568864,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2488822045.USD","02367","SG9999004311.SGD","BK1207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676113665","title":"花旗:中国化妆品第三季线上销售放缓 本地品牌表现较好","url":"https://stock-news.laohu8.com/highlight/detail?id=2676113665","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676113665?lang=zh_cn&edition=full","pubTime":"2026-10-20 16:36","pubTimestamp":1792485377,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,花旗发布研报称,中国化妆品线上销售增长于2026年第三季较上半年放缓,主要由国际品牌拖累,因618大促后进入淡季,与国家统计局零售数据走势一致。按品类计,彩妆属例外,本地品牌表现优于国际品牌。该行覆盖范围内,巨子生物品牌线上GMV正自低基数恢复,但第三季尚未足够令人鼓舞;毛戈平及贝泰妮则见季节性放缓,大致符合预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1509385.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2236285917.USD","IYF","LU1506573853.SGD","LU1244550494.USD","LU0098860793.USD","LU0320765646.SGD","LU2456880835.USD","LU0170899867.USD","BK4588","LU2125154778.USD","LU0130102774.USD","LU1366192091.USD","BK4585","LU0203347892.USD","LU0310800965.SGD","LU1791807156.HKD","BK1207","LU0130517989.USD","LU1244550221.USD","LU1201861249.SGD","LU1162221912.USD","SG9999004311.SGD","LU1267930227.SGD","BK4207","FTXO","LU2462157665.USD","LU2488822045.USD","LU0072461881.USD","01318","LU0203345920.USD","LU2360032135.SGD","TFNS","LU0128525689.USD","02367","LU0314106906.USD","LU1668664300.SGD","LU1074936037.SGD","LU2125154935.USD","BK4504","LU0477156953.USD","LU0980610538.SGD","BK4566","LU0052756011.USD","LU0648001328.SGD","LU0348767384.USD","BK4534","LU1244550577.SGD","LU0348766576.USD","LU0162691827.USD","LU1144417596.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675356348","title":"巨子生物推出新品牌1'me以我 天猫旗舰店上线首款精华液","url":"https://stock-news.laohu8.com/highlight/detail?id=2675356348","media":"北京商报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675356348?lang=zh_cn&edition=full","pubTime":"2026-10-14 17:47","pubTimestamp":1791971267,"startTime":"0","endTime":"0","summary":"10月14日,北京商报记者获悉,港股上市企业巨子生物推出全新品牌1'me以我,目前天猫官方旗舰店已正式开设,店铺内上架一款精华套装链接。记者浏览店铺页面看到,该链接对应一套3瓶装双仓精华,也是店铺内唯一一款产品。其客服人员表示,该商品目前还在预备当中,尚未正式开售,具体上市信息以官方发布为主。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610143895555741.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610143895555741.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2488822045.USD","BK1207","02367","SG9999004311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675397061","title":"三个月内回吐前期全部涨幅,“双十一”能否打响巨子生物(02367)股价翻身仗?","url":"https://stock-news.laohu8.com/highlight/detail?id=2675397061","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675397061?lang=zh_cn&edition=full","pubTime":"2026-10-14 12:23","pubTimestamp":1791951810,"startTime":"0","endTime":"0","summary":"得益于“618回暖+医美矩阵落地\"带来的预期修复,巨子生物(02367)股价曾在今年7月10日至7月29日走出一波明显的拉升行情,区间股价涨幅达到23.11%,并将股价重新拉回30港元以上。虽然在接下来三个月在多重因素影响,其股价回吐了前期涨幅,但如今“双十一”活动即将开启,更多投资者的目光也再次聚焦于这家港股医美龙头。回吐前期涨幅后,进入低位修复阶段智通财经APP观察到,自今年7月10日以来,巨","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1506909.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02367","SG9999004311.SGD","LU2488822045.USD","BK1207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674348831","title":"港股异动 | 大消费股多数上扬 国庆假期全国服务消费旺盛 低估值下消费配置动能有望上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2674348831","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674348831?lang=zh_cn&edition=full","pubTime":"2026-10-09 15:28","pubTimestamp":1791530909,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0054237671.USD","BK1233","LU0516422952.EUR","LU1282649810.SGD","LU2449936058.SGD","BK1500","LU0329678337.USD","LU1102505929.USD","LU0329678170.USD","IE0008368742.USD","09987","LU0417516902.SGD","LU0634319403.HKD","LU1303224171.USD","LU2348773727.SGD","LU0509642566.USD","IE00B8L5B284.USD","LU0650527681.SGD","LU2023250504.SGD","LU0048580855.USD","LU2279701549.SGD","02367","LU1282649067.USD","IE0008369823.USD","LU0231483743.USD","LU2242644610.SGD","LU0128525929.USD","SG9999001093.SGD","LU0048575426.USD","BK1597","LU0261950470.USD","LU3063872942.SGD","09961","IE0034224299.USD","LU0488056044.USD","LU0320764599.SGD","06862","SG9999000418.SGD","BK1583","LU0431992006.USD","06186","LU0417516738.SGD","LU0051755006.USD","LU1267930573.SGD","SG9999004311.SGD","09985","LU0823397103.USD","LU0455707207.USD","LU0737861699.HKD","LU0871576103.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175317765","title":"巨子生物9月股本维持稳定,未有新增发行或回购","url":"https://stock-news.laohu8.com/highlight/detail?id=1175317765","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175317765?lang=zh_cn&edition=full","pubTime":"2026-10-06 16:37","pubTimestamp":1791275862,"startTime":"0","endTime":"0","summary":"巨子生物控股有限公司于2026年10月6日发布了截至2026年9月30日的证券变动月报。公告显示,公司本月无新增发行、购回或注销股份,股本规模保持稳定。公司法定/注册股本方面,截至2026年9月末,巨子生物控股有限公司法定/注册股本合计保持在5,000,000,000股,面值均为每股0.00001美元,总额维持50,000美元,与上月无差异。本月内未因此发行新股或转让库存股份。截至本月末,公司股本合计维持在1,061,704,000股,整体股本结构稳定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673771762","title":"新消费概念板块受压 蔚来-SW(09866)跌2.74%、鸣鸣很忙(01768)跌2.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673771762","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673771762?lang=zh_cn&edition=full","pubTime":"2026-10-05 10:03","pubTimestamp":1791165816,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股新消费概念板块受压,截至发稿,蔚来-SW 跌2.74%,鸣鸣很忙跌2.03%,蜜雪集团跌1.95%,零跑汽车跌1.85%,名创优品跌1.87%,理想汽车-W跌1.78%,小米集团-W跌1.65%,毛戈平跌1.56%,沪上阿姨跌1.55%,卫龙美味跌1.54%,小鹏集团-W跌1.43%,巨子生物跌1.37%,布鲁可跌1.18%。该行指,多数消费品企业都认为第三季需求端持续受压,惟部分消费细分领域仍具韧性。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993016","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314109678.HKD","LU0797268264.HKD","IDRV","09896","LU0823413660.USD","LU0823426308.USD","09868","LU0594300419.USD","LU0054450605.USD","LU0441854154.USD","LU0051755006.USD","BK1588","LU1481107354.HKD","LU2187417386.USD","LU0143863784.USD","LU0449509016.USD","SG9999003461.SGD","LU0254981946.USD","LU0708995583.HKD","XPEV","LU0307460666.USD","LU2087589342.USD","IE00B3M56506.USD","LU1981816686.USD","LU1188198961.HKD","LU0823426480.USD","LU0918141705.HKD","LU2097828557.USD","LU0531970944.HKD","LU0164865239.USD","LU2039709279.SGD","LU0345776255.USD","LU2351347302.SGD","LU1105468828.SGD","LU2476274720.SGD","LU0235996351.USD","MIUmain","HXXD.SI","LU0320764599.SGD","BK1523","00325","HK0000286598.CNH","LU0531971595.HKD","LU0449515922.USD","LU0572944931.SGD","LU0210526637.USD","BK1132","HK0000165453.HKD","LU0823397103.USD","LU0348814723.USD","LU1794554557.SGD","LU2929501877.USD","LU2097828805.USD","BK1249","LU0348827113.USD","LU2778985437.USD","LU0823041008.USD","02589","LU2152927971.USD","BK1589","LU0084288322.USD","LU0605514214.HKD","BK1521","LU1868837565.USD","LU0823039010.USD","LU0417516902.SGD","BK1575","LU0499858602.USD","LU0327786744.USD","LU0359201612.USD","IE0032431581.USD","LU1961090484.USD","LU2097828474.EUR","LU0348735423.USD","LU0823040885.USD","LU0918141887.USD","LU0348816934.USD","LU0588546209.SGD","LU0039217434.USD","LU0700851271.USD","LU0348767384.USD","LU0231483743.USD","BK1587","XIACY","LU0052750758.USD","LU0634319403.HKD","02015","LU0540923850.HKD","IE0034224299.USD","LU2476274308.USD","DRGN","BK1502","81810","LU0359202008.SGD","LU0359201885.HKD","LU0164872284.USD","LU0348825331.USD","LU0611395673.USD","SG9999002463.SGD","LU0499858438.USD","BK1615","LU0561508036.HKD","LU1282648689.USD","LU1770034418.SGD","LU2488822045.USD","LU0211977185.USD","LU1023057109.AUD","LU0456827905.SGD","BK1616","01810","BK1207","BK1506","LU1303224171.USD","LU1868838027.USD","LU1328277881.USD","LU1719994722.HKD","LU2097828714.EUR","LU2226246903.HKD","LI","LU0417516738.SGD","02367","LU0117841782.USD","02097","LU2257852520.SGD","LU0149721374.USD","LU0823038988.USD","LU0463099449.HKD","NIO.SI","BK1610","09866","LU0593848301.USD","01768","LU1956131251.USD","LU0650527681.SGD","LU1323998911.USD","BK1237","MNSO","LU0675040207.SGD","LU0169518387.USD","LU1813983027.USD","SG9999004311.SGD","LU0143863198.USD","LU0164880469.USD","LU0345775950.USD","LU0244354667.USD","LU2097828631.EUR","LU0348766576.USD","LU1880383440.USD","LU0823397285.USD","LU2294711473.HKD","LU0871576103.HKD","LU2399975544.HKD","BK1618","LU1808992512.USD","BK1539","LU0823413587.USD","LU1251922891.USD","LU1720050803.USD","01318","LU1880383366.USD","SG9999001093.SGD","NIO","BK1213","LU1770036033.HKD","LU0326950275.SGD","09863","LU0594300179.USD","BK1607","LU0214875030.USD","BK1119","LU0456846285.SGD","BK1193","BK1246","BK1233","09985"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671269514","title":"【券商聚焦】中信证券:关注假期场景消费品类格局变化","url":"https://stock-news.laohu8.com/highlight/detail?id=2671269514","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671269514?lang=zh_cn&edition=full","pubTime":"2026-09-29 08:40","pubTimestamp":1790642456,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券表示,2026年中秋国庆假期特征具备“请3休13”长假条件,或推动出游需求旺盛,总体或导致需求从居住地转向出行目的地、商品型消费进一步转向服务型消费。随着国货美妆大单品的建立,美妆品类逐步进入以食品、酒类为主的礼品赛道,关注发力礼品营销的美妆品牌;长假有望催化医美机构端景气度延续,产品端新品迭出,关注动销旺季的新品验证;珠宝赛道需关注海内外黄金价差及总体动销,同时不可忽视婚庆需求压力。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992673","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1516","LU0348767384.USD","LU2242644610.SGD","LU2289578879.USD","BK0183","BK0196","BK0276","02657","BK0028","LU0348766576.USD","BK1147","LU1997245094.SGD","LU0405327148.USD","BK1207","LU1146622755.USD","SG9999004311.SGD","LU2580892862.HKD","LU1580142542.USD","KCE","LU1655091616.SGD","600030","LU2580892789.USD","BK1521","02145","LU2488822045.USD","LU1794554557.SGD","LU2495084118.USD","BK0012","02367","LU0405327494.USD","LU1064130708.USD","LU1064131003.USD","LU2148510915.USD","BK1564","LU1255011170.USD","LU1720050803.USD","BK0188","LU1820825898.SGD","LU1997244956.HKD","06030","LU1997245177.USD","LU0455707207.USD","LU1328615791.USD","01318","LU1781817850.SGD","LU0502904849.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130879572","title":"巨子生物2026年中期营收29.2亿元,经调整净利润9.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1130879572","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1130879572?lang=zh_cn&edition=full","pubTime":"2026-09-24 17:37","pubTimestamp":1790242661,"startTime":"0","endTime":"0","summary":"根据巨子生物公告,2026年上半年实现营收29.2亿元,同比下降6.3%。同期经调整净利润约为9.5亿元,同比下降21.5%。毛利率由上年同期的81.7%下降至79.5%。公司报告期内销售及经销开支约为12.67亿元,同比上涨19.7%;行政开支约为79.9百万元,同比下降3.3%;研发支出约为0.46亿元,占营收比约1.6%。经营活动所产生的现金净额约为7.90亿元,高于上年同期的7.16亿元。公告指出,可复美营收下滑主要因市场竞争加剧及渠道结构调整。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"巨子生物2026年中期营收29.2亿元,经调整净利润9.5亿元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669115400","title":"【券商聚焦】华创证券维持巨子生物(02367)推荐评级 指医美新品打开增长空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2669115400","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669115400?lang=zh_cn&edition=full","pubTime":"2026-09-22 13:40","pubTimestamp":1790055658,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华创证券发布研报指,巨子生物 2026年上半年业绩阶段性承压,但医美新品打开增长新空间。业务拆分方面,核心品牌可复美收入23.47亿元,同比-7.7%,占总收入80.4%,下滑主要受行业竞争及达播端收入结构性调整影响,下半年低基数预计增速环比改善;可丽金收入4.99亿元,同比-0.8%,基本保持稳定。618大促期间可复美与可丽金线上全渠道GMV分别同比增长超25%和30%。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992194","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161027","KCE","02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668130949","title":"【券商聚焦】华泰证券:韩妆增长逻辑拆解与国潮美妆出海展望","url":"https://stock-news.laohu8.com/highlight/detail?id=2668130949","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668130949?lang=zh_cn&edition=full","pubTime":"2026-09-18 08:40","pubTimestamp":1789692020,"startTime":"0","endTime":"0","summary":"华泰证券认为K-Beauty以韩流带动的审美潮流、高效快反的ODM供应链、高转化的内容电商等为抓手,成功走向欧美。华泰证券认为,国货同样具备供应链/营销/体验等优势,国潮文化或成东方美出海的重要催化剂。","market":"us","thumbnail":"https://static.szfiu.com/news/20250106/ODRhMzI4MWM5YTc2MTY1NjgxNGQwMTEwODUwOTcyNzQ0Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ODRhMzI4MWM5YTc2MTY1NjgxNGQwMTEwODUwOTcyNzQ0Mg==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991906","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0039217434.USD","LU0348767384.USD","LU1808992512.USD","BK0188","BK0012","BK1207","LU0164865239.USD","LU0348766576.USD","BK0028","LU1580142542.USD","LU1064130708.USD","LU1781817850.SGD","LU2148510915.USD","BK0183","LU2242644610.SGD","LU1934453819.USD","02145","LU1979443071.USD","LU1328615791.USD","02657","LU0502904849.HKD","LU0871576103.HKD","601688","LU1064131003.USD","02367","01318","BK0276","SG9999004311.SGD","LU2488822045.USD","KCE","LU0455707207.USD","LU0531971595.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667695232","title":"长坡厚雪 “巨子”焕新","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695232","media":"经济参考报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667695232?lang=zh_cn&edition=full","pubTime":"2026-09-15 04:27","pubTimestamp":1789417674,"startTime":"0","endTime":"0","summary":"2026年初秋,西安。巨子生物基础研发中心内,精密仪器的指示灯微微闪烁,科研人员紧盯着屏幕上跳动的实验数据。在实验室之外,市场团队正在为可丽金“芯生”753胶原针的全国机构铺货忙碌。这款新上市的产品,短短两个月便已进入约300家医美机构——这也意味着,巨子生物这家重组胶原蛋白领域的龙头企业,正式踏入了专业医美注射这条新赛道。对巨子生物而言,2026年注定是希望与压力交织的一年。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609153873814080.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609153873814080.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02367","LU2488822045.USD","SG9999004311.SGD","BK1207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666630557","title":"【券商聚焦】招银国际:重点港股消费股的仓位结构趋于稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=2666630557","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666630557?lang=zh_cn&edition=full","pubTime":"2026-09-10 13:21","pubTimestamp":1789017678,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际表示,截至9月8日的两周,重点港股消费股的仓位结构趋于稳定。平均未平仓沽空占自由流通股比例微升0.1ppt至8.8%,仍处于近半年高位附近;随着中报季成交回归常态,空头回补天数由8.5天回落至8.3天。南下持股占自由流通股比例上升0.8ppt至31.7%,为1Q26以来首次显著回升,尽管8月南向资金整体净流入约104亿港元,较7月的约629亿港元明显放缓。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991290","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0039217434.USD","LU0149721374.USD","LU0345776255.USD","LU0871576103.HKD","BK1246","LU0164865239.USD","BK1616","06181","SGXZ90724238.SGD","BK1544","SG9999001051.SGD","LU0359201885.HKD","LU2488822045.USD","02097","SGXZ86797644.SGD","LU1880383366.USD","SG9999002950.SGD","LU0359202008.SGD","LU0359201612.USD","LU1770036033.HKD","IE0034224299.USD","LU0307460666.USD","LU0823426480.USD","KCE","LU0164880469.USD","LU0231483743.USD","LU0211977185.USD","01364","00325","LU0348767384.USD","LU0531971595.HKD","LU0593848301.USD","01318","LU0611395673.USD","BK1233","02150","LU1023057109.AUD","09992","159735","09896","LU0499858438.USD","LU0572944931.SGD","02367","LU2543165471.USD","02589","BK1587","LU0823426308.USD","BK1207","02555","LU1880383440.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xajuzi.com","stockEarnings":[{"period":"1week","weight":0.0434},{"period":"1month","weight":-0.0923},{"period":"3month","weight":-0.273},{"period":"6month","weight":-0.3035},{"period":"1year","weight":-0.4324},{"period":"ytd","weight":-0.3491}],"compareEarnings":[{"period":"1week","weight":0.051},{"period":"1month","weight":0.0146},{"period":"3month","weight":-0.0462},{"period":"6month","weight":-0.0724},{"period":"1year","weight":-0.0757},{"period":"ytd","weight":-0.0448}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"巨子生物控股有限公司是一家主要从事基于生物活性成分的美丽与健康产品的研发、制造及销售业务的投资控股公司。该公司的主要产品包括功效性护肤品、医用敷料等专业皮肤护理产品,以及保健食品及其他产品。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.063748},{"month":2,"riseRate":0.75,"avgChangeRate":0.082293},{"month":3,"riseRate":0.75,"avgChangeRate":0.04973},{"month":4,"riseRate":0.75,"avgChangeRate":0.023756},{"month":5,"riseRate":0.25,"avgChangeRate":-0.038833},{"month":6,"riseRate":0.25,"avgChangeRate":-0.059254},{"month":7,"riseRate":0.5,"avgChangeRate":0.005281},{"month":8,"riseRate":0.5,"avgChangeRate":-0.026722},{"month":9,"riseRate":0.5,"avgChangeRate":0.033714},{"month":10,"riseRate":0.25,"avgChangeRate":-0.142234},{"month":11,"riseRate":0.5,"avgChangeRate":0.025728},{"month":12,"riseRate":0.25,"avgChangeRate":0.047111}],"exchange":"SEHK","name":"巨子生物","nameEN":"GIANT BIOGENE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"巨子生物(02367)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供巨子生物(02367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"巨子生物,02367,巨子生物股票,巨子生物股票老虎,巨子生物股票老虎国际,巨子生物行情,巨子生物股票行情,巨子生物股价,巨子生物股市,巨子生物股票价格,巨子生物股票交易,巨子生物股票购买,巨子生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"巨子生物(02367)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供巨子生物(02367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}